INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 231 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,140,000 | -19.7% | 159,284 | +4.0% | 0.01% | -12.5% |
| Q2 2021 | $1,420,000 | +3.4% | 153,222 | +3.6% | 0.01% | -11.1% |
| Q1 2021 | $1,373,000 | +0.7% | 147,950 | -4.0% | 0.01% | 0.0% |
| Q4 2020 | $1,364,000 | -11.0% | 154,113 | +16.6% | 0.01% | -18.2% |
| Q3 2020 | $1,533,000 | -28.9% | 132,147 | -77.1% | 0.01% | -38.9% |
| Q1 2019 | $2,156,000 | -6.7% | 578,013 | +0.1% | 0.02% | -10.0% |
| Q4 2018 | $2,311,000 | -17.7% | 577,634 | +14.4% | 0.02% | +11.1% |
| Q3 2018 | $2,807,000 | +42.0% | 504,818 | +0.1% | 0.02% | +38.5% |
| Q2 2018 | $1,977,000 | -16.8% | 504,426 | -0.1% | 0.01% | +116.7% |
| Q1 2018 | $2,375,000 | -2.2% | 504,709 | +90.8% | 0.01% | 0.0% |
| Q4 2014 | $2,428,000 | +8.5% | 264,470 | +16.4% | 0.01% | +20.0% |
| Q3 2014 | $2,238,000 | – | 227,185 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 648,800 | $1,920,000 | 1.55% |
| Round Table Services, LLC | 339,391 | $998,000 | 0.31% |
| ARK Investment Management | 3,955,017 | $11,628,000 | 0.29% |
| Nikko Asset Management Americas, Inc. | 4,884,100 | $14,359,000 | 0.28% |
| WASATCH ADVISORS LP | 6,735,726 | $19,803,000 | 0.19% |
| Cedar Brook Financial Partners, LLC | 41,500 | $122,000 | 0.06% |
| Unified Trust Company, N.A. | 15,716 | $46,000 | 0.03% |
| Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors | 13,500 | $40,000 | 0.03% |
| STONERIDGE INVESTMENT PARTNERS LLC | 16,914 | $50,000 | 0.02% |
| Sumitomo Mitsui Trust Holdings, Inc. | 4,884,100 | $14,359,000 | 0.01% |